FeesSafety
Pluang+
Home/Explore/US Market Price/Stocks/BMY
icon
Up to 4x
Us company
Asset icon - trade crypto, stocks, and gold on Pluang

Bristol-Myers Squibb Co (BMY) Stock Price Today

TechnicalsFundamentalsFinancialsNewsCorp ActionAboutCompare
24H
1W
1M
3M
YTD
1Y
5Y

Aura AI Summary

Bristol Myers Squibb (BMY) trades at $61.61, up 0.21% with a bullish technical signal supported by moving averages. The stock shows strong profitability with 18.87% net income margin and 46.7% ROE, trading at attractive valuations (P/E 13.57, P/S 2.56). Recent quarterly earnings consistently beat expectations, while FDA approval for Camzyos expansion and positive pipeline developments provide growth catalysts. Cash flow remains healthy with $14.16B operating cash flow in 2025.
BMY presents a compelling value opportunity with discounted valuation and dividend yield, though patent cliff concerns and debt levels require monitoring. Analyst consensus targets $65.75 with 45% buy ratings, suggesting 6.7% upside potential. The company's growth portfolio expansion and cost management support medium-term outlook, but competitive pressures in oncology/immunology remain key risks.
Read full analysis

Key Stats

  • Market Cap
    $125.73B
  • Volume
    7,747,772
  • Sector
    Health
  • 52W High
    $68.09
  • 52W Low
    $42.60
  • Typical Hold Time
    91 Days
  • Enterprise Value
    $159.72B
  • Div Yield
    4.09%
  • Trading Activity
    0% Sell | 100% Buy
$61.51
52W Low: $42.6
29 Oct 2025
52W High: $68.09
03 Sep 2026

Track Bristol-Myers Squibb Co (BMY) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Bristol-Myers Squibb Co has traded between a low of $42.6 and a high of $68.09, highlighting its annual price range. Buy and sell Bristol-Myers Squibb Co shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

About Bristol-Myers Squibb Co

Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Unlike some of its more diversified peers, Bristol has exited several nonpharmaceutical businesses to focus on branded specialty drugs, which tend to support strong pricing power.

Most Recent News

Content is generated by Aura AI

Stella-Jones executives to present at RBC Capital Markets 2026 Global Industrials Conference

Stella-Jones Inc. announced that its CEO Eric Vachon and CFO Silvana Travaglini will participate in the RBC Capital Markets 2026 Global Industrials Conference in New York on November 16, 2026. The company will hold meetings with institutional investo...

Market News
41 minutes ago
Na
Neutral
Stella-Jones executives to present at RBC Capital Markets 2026 Global Industrials Conference

Stella-Jones executives to present at RBC Industrial Products Conference in New York on Nov 16, 2026

Stella-Jones Inc. announced that its CEO Éric Vachon and CFO Silvana Travaglini will attend the RBC Capital Markets 2026 Global Industrial Products Conference in New York on November 16, 2026. They will meet with institutional investors to discuss th...

Market News
41 minutes ago
Na
Neutral
Stella-Jones executives to present at RBC Industrial Products Conference in New York on Nov 16, 2026

Copenhagen Airports appoints Sofie Mørck Jarl as new CFO starting March 2027

Copenhagen Airports has named Sofie Mørck Jarl as its new Chief Financial Officer, effective by March 1, 2027. She previously held senior finance roles at Novo Nordisk and brings experience in strategy, financial leadership, and managing large invest...

Market News
1 hour ago
Na
Neutral
Copenhagen Airports appoints Sofie Mørck Jarl as new CFO starting March 2027
Catch up fast with Aura AI
Get an AI-generated news summary for this asset in seconds.

People also bought

Frequently Asked Questions

US stocks trading hours: Monday - Friday (Except for US public holidays) Time: 21.30 - 04.00 WIB 20.30 - 03.00 WIB (Daylight Savings Time*) *The next Daylight Savings is scheduled to begin on March 13, 2022 and ends on November 6, 2022. You can place limit orders outside of the trading hours, but it can only be executed during trading hours. For illustration, a stock is currently trading at $10 per share, but you only want to pay $7 per share at most. Let’s say you set your limit price to $7 at 18.00. Your order will be executed when the market is open at 21.30 if the stock drops from $10 to $7 or lower. Similarly, if the stock price doesn’t drop to $7, your order won’t be executed.
Yes, you are eligible to receive dividend payment if and when the company pays them on one condition: minimum net dividend paid is at least $0.01. Net dividend is gross dividend subtracted by 15% withholding tax.
Yes, it is. US Stocks risk is managed by PT PG Berjangka which is licensed by Badan Pengawas Perdagangan Berjangka Komoditi (BAPPEBTI), and your investment is guaranteed by Jakarta Futures Exchange (JFX) and Indonesian Clearing House (KBI).
Pluang charges a fixed transaction fee of 0.30% for regular users and 0.20% for Pluang Plus members, including VAT to cover the exchange fees and operational costs.
US Stocks, ETFs, and Options are facilitated by PT PG Berjangka in its capacity as a Licensed Derivatives Broker supervised by the Financial Services Authority of Indonesia (OJK) for financial derivative products with underlying securities. All transactions are recorded on the Jakarta Futures Exchange (JFX) and the Indonesian Futures Clearing House (KBI). In addition, PT PG Berjangka is also a Licensed Futures Broker supervised by the Commodity Futures Trading Regulatory Agency (Bappebti). Read our product’s Terms and Conditions

All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.

Key Stats

  • Market Cap
    $125.73B
  • Volume
    7,747,772
  • Sector
    Health
  • 52W High
    $68.09
  • 52W Low
    $42.60
  • Typical Hold Time
    91 Days
  • Enterprise Value
    $159.72B
  • Div Yield
    4.09%
  • Trading Activity
    0% Sell | 100% Buy
$61.51
52W Low: $42.6
29 Oct 2025
52W High: $68.09
03 Sep 2026

Track Bristol-Myers Squibb Co (BMY) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Bristol-Myers Squibb Co has traded between a low of $42.6 and a high of $68.09, highlighting its annual price range. Buy and sell Bristol-Myers Squibb Co shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

Let’s invest in this asset by signing up or download!